In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity, and apoptosis

Biochemical Pharmacology

Volumn 60, Issue 10, 2000, Pages 1467-1473

  Zhu, Zongjian ^a   Jiang, Weiqin ^a   Ganther, Howard E ^b   Ip, Clement ^c   Thompson, Henry J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Cell growth; DNA integrity; Selenium; Selenocysteine

Indexed keywords

ANTINEOPLASTIC AGENT; CELL DNA; CYSTEINE DERIVATIVE; MUTANT PROTEIN; ORGANOSELENIUM DERIVATIVE; PROTEIN P53; S ALLYLCYSTEINE; SE ALLYLSELENOCYSTEINE; SE METHYLSELENOCYSTEINE; SE PROPYLSELENOCYSTEINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG STRUCTURE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMAL; APOPTOSIS; CELL DIVISION; COMPARATIVE STUDY; DNA; DNA DAMAGE; LYASES; MICE; ORGANOSELENIUM COMPOUNDS; SELENOCYSTEINE; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0034670170     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00461-5     Document Type: Article

References (24)

1. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 128:1998;1845-1854.
2. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention Complexities with thioredoxin reductase . Carcinogenesis. 9:1999;1657-1666.
3. Andreadou I., Menge W.M.P.B., Commandeur J.N.M., Worthington E.A., Vermeulen N.P.E. Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds Evaluation of kinetics of β-elimination reactions in rat renal cytosol . J Med Chem. 39:1996;2040-2046.
4. Ip C., Ganther H.E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis. 13:1992;1167-1170.
5. Ip C., Zhu Z., Thompson H.J., Lisk D., Ganther H.E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res. 19:1999;2875-2880.
6. Ganther H.E., Lawrence J.R. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron. 53:1997;12299-12310.
7. Thompson H.J., Wilson A., Lu J., Singh M., Jiang C., Upadhyaya P., El-Bayoumy K., Ip C. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis. 15:1994;183-186.
8. Lu J., Jiang C., Kaeck M., Ganther H., Vadhanavikit S., Ip C., Thompson H. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol. 50:1995;213-219.
9. Medina D., Kittrell F.S., Liu Y.J., Schwartz M. Morphological and functional properties of TM preneoplastic mammary outgrowths. Cancer Res. 53:1993;663-667.
10. Bernhardt G., Reile H., Birnbock H., Spruss T., Schonenberger H. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol. 118:1992;35-43.
11. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:1988;184-191.
12. Collins A., Dusinska M., Franklin M., Somorovska M., Petrovska H., Duthie S., Fillion L., Panayiotidi M., Raslova K., Vaughan N. Comet assay in human biomonitoring studies Reliability, validation, and applications . Environ Mol Mutagen. 30:1997;139-146.
13. Collins A.R., Duthie S.J., Dobson V.L. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis. 14:1993;1733-1735.
14. Schneider J.E., Price S., Maidt L., Gutteridge J.M.C., Floyd R.A. Methylene blue plus light mediates 8-hydroxy 2′-deoxyguanosine formation in DNA preferentially over strand breakage. Nucleic Acids Res. 18:1990;631-635.
15. Duke C and Cohen JJ, Morphological and biochemical assays of apoptosis. In: Current Protocols in Immunology (Eds. Coligan JE and Kruisbeak AM), pp. 3.17.1-3.17.16. John Wiley, New York, 1992.
16. Snedecor GW and Cochran WG, Statistical Methods, 6th Edn, pp, 135-317. Iowa State University, Ames, IA, 1967.
17. Haegele A.D., Wolfe P., Thompson H.J. X-radiation induces 8-hydroxy-2′-deoxyguanosine formation in vivo in rat mammary gland DNA. Carcinogenesis. 19:1998;1319-1321.
18. Kennedy A.R., Fox M., Murphy G., Little J.B. Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci USA. 77:1980;7262-7266.
19. Plappert U., Raddatz K., Roth S., Fliedner T.M. DNA-damage detection in man after radiation exposure - The comet assay - Its possible application for human biomonitoring. Stem Cells. 13:(Suppl 1):1995;215-222.
20. Wang D., Kreutzer D.A., Essigmann J.M. Mutagenicity and repair of oxidative DNA damage Insights from studies using defined lesions . Mutat Res. 400:1998;99-115.
21. Ripp S.L., Overby L.H., Philpot R.M., Elfarra A.A. Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA-expressed flavin-containing mono-oxygenases Studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine . Mol Pharmacol. 51:1997;507-515.
22. Jin L., Baillie T.A. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem Res Toxicol. 10:1997;318-327.
23. Eisenbrand G., Schuhmacher J., Golzer P. The influence of glutathione and detoxifying enzymes on DNA damage induced by 2-alkenals in primary rat hepatocytes and human lymphoblastoid cells. Chem Res Toxicol. 8:1995;40-46.
24. Dypbukt J.M., Atzori L., Edman C.C., Grafstrom R.C. Thiol status and cytopathological effects of acrolein in normal and xeroderma pigmentosum skin fibroblasts. Carcinogenesis. 14:1993;975-980.